KOLs working with Adaptimmune
5 key opinion leaders with clinical trial sponsorships or reported industry payments from Adaptimmune. Relationships are drawn from ClinicalTrials.gov sponsor records and CMS Open Payments, with every number cited to its source.
Profiles
Richard Finn, MD
David Geffen School of Medicine at UCLA
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileBreastHematology / OncologyWest · CA
- 775
- publications
- 102
- h-index
- 8
- trials
View profile →
David Hong, MD
The University of Texas MD Anderson Cancer Center
Enriched profileLungMedical OncologySouth Central · TX
- 1,978
- publications
- 107
- h-index
- 42
- trials
View profile →
Edward Stadtmauer, MD
University of Pennsylvania
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileHematologyHematologyNortheast · PA
- 630
- publications
- 88
- h-index
- 7
- trials
View profile →
Frederick Locke, MD
H. Lee Moffitt Cancer Center and Research Institute
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileMyelomaHematology / OncologySoutheast · FL
- 863
- publications
- 62
- h-index
- 8
- trials
View profile →
Richard Maziarz, MD
Oregon Health & Science University
Enriched profilefindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLeukemiaHematology / OncologyWest · OR
- 720
- publications
- 86
- h-index
- 9
- trials
View profile →
Filter, sort, and export all 5 working with Adaptimmune in the directory